{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:01:04Z","timestamp":1781881264970,"version":"3.54.5"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119098","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:34:37Z","timestamp":1770694477000},"page":"119098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-coding RNA Trojan nanocarriers in CRC: Mechanistic crossroads and therapeutic challenges"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-407X","authenticated-orcid":false,"given":"Mingrong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from globocan","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41575-023-00841-9","article-title":"Changing epidemiology of colorectal cancer - birth cohort effects and emerging risk factors","volume":"21","author":"Murphy","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib3","first-page":"229","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA a cancer journal clinicians"},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib4","first-page":"24","article-title":"The mechanistic roles of ncrnas in promoting and supporting chemoresistance of colorectal cancer","volume":"7","author":"Micallef","year":"2021","journal-title":"NonCoding RNA"},{"issue":"4","key":"10.1016\/j.biopha.2026.119098_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12032-023-01980-4","article-title":"The critical role of circular rnas in drug resistance in gastrointestinal cancers","volume":"40","author":"Samavarchi Tehrani","year":"2023","journal-title":"Med. Oncol. (North. Lond. Engl. )"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1186\/s12885-023-11571-1","article-title":"Circular rna znf800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer","volume":"23","author":"Rengganaten","year":"2023","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.biopha.2026.119098_bib7","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2174\/0113816128291321240329050945","article-title":"Colorectal cancer stem cell biomarkers: biological traits and prognostic insights","volume":"30","author":"Soleimani","year":"2024","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib8","article-title":"Wfdc3 sensitizes colorectal cancer to chemotherapy by regulating atm\/atr kinase signaling pathway","volume":"39","author":"Yang","year":"2025","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/biomedicines13030642","article-title":"Advances in targeted and chemotherapeutic strategies for colorectal cancer: current insights and future directions","volume":"13","author":"Shaham","year":"2025","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.biopha.2026.119098_bib10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.3390\/cancers14092280","article-title":"Long non-coding rnas as potential regulators of emt-related transcription factors in colorectal cancer-a systematic review and bioinformatics analysis","volume":"14","author":"Pavli\u010d","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biopha.2026.119098_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/kjm2.12844","article-title":"Mechanical shear flow regulates the malignancy of colorectal cancer cells","volume":"40","author":"Tseng","year":"2024","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s43556-022-00110-2","article-title":"Targeting the pi3k\/akt\/mtor and raf\/mek\/erk pathways for cancer therapy","volume":"3","author":"Li","year":"2022","journal-title":"Mol. Biomed."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41420-024-01832-8","article-title":"Long noncoding rna h19: functions and mechanisms in regulating programmed cell death in cancer","volume":"10","author":"Xia","year":"2024","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cbin.12270","article-title":"Wnt\/\u03b2-catenin pathway as a link between therapy resistance-driven epithelial-mesenchymal transition and stemness in colorectal cancer","volume":"49","author":"Rocha","year":"2025","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12935-025-03758-2","article-title":"Molecular and phenotypic characterization of 5-fu resistant colorectal cancer cells: toward enrichment of cancer stem cells","volume":"25","author":"Babajnai","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib16","article-title":"Long non-coding rnafoxd1-as1 modulated ctcs epithelial-mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging mir-615-3p","volume":"7","author":"Guo","year":"2024","journal-title":"Cancer reports (Hoboken N. J. )"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib17","first-page":"71","article-title":"Mir-145 suppresses epithelial-mesenchymal transition by targeting stem cells in ewing sarcoma cells","volume":"122","author":"Guzel Tanoglu","year":"2021","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.biopha.2026.119098_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.709324","article-title":"Research progress on the functions and mechanism of circrna in cisplatin resistance in tumors","volume":"12","author":"Mu","year":"2021","journal-title":"Front. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cac2.12138","article-title":"Emt-associated micrornas and their roles in cancer stemness and drug resistance","volume":"41","author":"Pan","year":"2021","journal-title":"Cancer communications (London England)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4149\/neo_2020_200417N414","article-title":"Exosomal transfer of circular rna fbxw7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging mir-18b-5p","volume":"68","author":"Xu","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.biopha.2026.119098_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114228","article-title":"Lncrna regulation: new frontiers in epigenetic solutions to drug chemoresistance","volume":"189","author":"Zhou","year":"2021","journal-title":"Biochem. Pharm."},{"issue":"26","key":"10.1016\/j.biopha.2026.119098_bib22","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/0929867329666220329203032","article-title":"The emerging role of emt-related lncrnas in therapy resistance and their applications as biomarkers","volume":"29","author":"Kichi","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119098_bib23","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1007\/s10238-023-01179-x","article-title":"Lncrna malat1 signaling pathway and clinical applications in overcome on cancers metastasis","volume":"23","author":"Mazarei","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib24","first-page":"281","article-title":"Circpak1 promotes the progression of hepatocellular carcinoma via modulation of yap nucleus localization by interacting with 14-3-3\u03b6","volume":"41","author":"Hao","year":"2022","journal-title":"Journal experimental clinical cancer research CR"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13072-024-00554-6","article-title":"Epigenetic frontiers: mirnas, long non-coding rnas and nanomaterials are pioneering to cancer therapy","volume":"17","author":"Prabhakaran","year":"2024","journal-title":"Epigenetics Chromatin"},{"issue":"4","key":"10.1016\/j.biopha.2026.119098_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402933","article-title":"Nanocarrier-mediated rna delivery platform as a frontier strategy for hepatic disease treatment: challenges and opportunities","volume":"14","author":"Fan","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12032-023-02273-6","article-title":"Unraveling the multifaceted role of epcam in colorectal cancer: an integrated review of its function and interplay with non-coding rnas","volume":"41","author":"Jiang","year":"2023","journal-title":"Med. Oncol. (North. Lond. Engl. )"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","article-title":"Engineered exosomes for targeted co-delivery of mir-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer","volume":"18","author":"Liang","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119098_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12935-018-0660-6","article-title":"Predictive role of uca1-containing exosomes in cetuximab-resistant colorectal cancer","volume":"18","author":"Yang","year":"2018","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.biopha.2026.119098_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113865","article-title":"Vps9d1-as1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer","volume":"384","author":"Yang","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"11","key":"10.1016\/j.biopha.2026.119098_bib31","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.21037\/tcr-24-933","article-title":"Abalon regulates mitophagy and 5-fu sensitivity in colorectal cancer via pink1-parkin pathway","volume":"13","author":"Liu","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119098_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-015-0372-7","article-title":"Mir-21 and mir-145 cooperation in regulation of colon cancer stem cells","volume":"14","author":"Yu","year":"2015","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2026.119098_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3892\/or.2021.8170","article-title":"Microrna\u20118063 targets heterogeneous nuclear ribonucleoprotein ab to inhibit the self\u2011renewal of colorectal cancer stem cells via the wnt\/\u03b2\u2011catenin pathway","volume":"46","author":"Chen","year":"2021","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119098_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/abbs\/gmy040","article-title":"Mir-223 promotes the doxorubicin resistance of colorectal cancer cells via regulating epithelial-mesenchymal transition by targeting fbxw7","volume":"50","author":"Ding","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib35","first-page":"98","article-title":"Decreasing lncrna hotair expression inhibits human colorectal cancer stem cells","volume":"8","author":"Dou","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib36","doi-asserted-by":"crossref","first-page":"38444","DOI":"10.1038\/s41598-025-24202-5","article-title":"Rna sequencing reveals novel lncrna modulators in gemini nanocurcumin-treated colorectal cancer cells","volume":"15","author":"Zibaei","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib37","article-title":"Biomimetic nano-delivery of small-molecule piceatannol modulates tumor stemness and suppresses colorectal cancer metastasis via hippo\/yap1\/sox9 signaling","volume":"21","author":"Zhou","year":"2025","journal-title":"Small (Weinh. der Bergstr. Ger. )"},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1535-7163.MCT-19-0668","article-title":"Tankyrase inhibitors target colorectal cancer stem cells via axin-dependent downregulation of c-kit tyrosine kinase","volume":"19","author":"Jang","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/cells11030511","article-title":"Comparison of colorectal cancer stem cells and oxaliplatin-resistant cells unveils functional similarities","volume":"11","author":"Rodr\u00edguez-Fanjul","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.biopha.2026.119098_bib40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/onc.2016.299","article-title":"Cd51 correlates with the tgf-beta pathway and is a functional marker for colorectal cancer stem cells","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.biopha.2026.119098_bib41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jpp\/rgab051","article-title":"Drug resistance via radixin-mediated increase of p-glycoprotein membrane expression during snai1-induced epithelial-mesenchymal transition in hepg2 cells","volume":"73","author":"Kamioka","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119098_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41419-022-05111-1","article-title":"Lactate promotes metastasis of normoxic colorectal cancer stem cells through pgc-1\u03b1-mediated oxidative phosphorylation","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib43","first-page":"787","article-title":"Transglutaminase 2 regulates self-renewal and stem cell marker of human colorectal cancer stem cells","volume":"38","author":"Kang","year":"2018","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cas.14253","article-title":"Regulation of atp-binding cassette subfamily b member 1 by snail contributes to chemoresistance in colorectal cancer","volume":"111","author":"Wang","year":"2020","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25053-0","article-title":"Dyrk2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance","volume":"12","author":"Wu","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1248\/bpb.b20-00693","article-title":"Functional alterations of multidrug resistance-associated proteins 2 and 5, and breast cancer resistance protein upon snail-induced epithelial-mesenchymal transition in hcc827 cells","volume":"44","author":"Yano","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2026.119098_bib47","article-title":"Kdm3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through wnt\/\u03b2-catenin signalling","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib48","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1038\/s41598-018-24903-0","article-title":"Jib-04, a small molecule histone demethylase inhibitor, selectively targets colorectal cancer stem cells by inhibiting the wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119098_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27159","article-title":"Gtp binding protein 2 maintains the quiescence, self-renewal, and chemoresistance of mouse colorectal cancer stem cells via promoting wnt signaling activation","volume":"10","author":"Ke","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib50","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/jcmm.14882","article-title":"Kr\u00fcppel-like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the tgf-\u03b21\/smad\/snail pathway","volume":"24","author":"Leng","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119098_bib51","article-title":"Modified shenlingbaizhu decoction represses the pluripotency of colorectal cancer stem cells by inhibiting tgf-\u03b2 mediated emt program","volume":"103","author":"Dai","year":"2022","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"26","key":"10.1016\/j.biopha.2026.119098_bib52","doi-asserted-by":"crossref","first-page":"E5990","DOI":"10.1073\/pnas.1801348115","article-title":"Hypoxic tumor microenvironment activates gli2 via hif-1\u03b1 and tgf-\u03b22 to promote chemoresistance in colorectal cancer","volume":"115","author":"Tang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biopha.2026.119098_bib53","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/stem.2320","article-title":"Igf\/stat3\/nanog\/slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer","volume":"34","author":"Yao","year":"2016","journal-title":"Stem Cells (Dayt. Ohio)"},{"issue":"8","key":"10.1016\/j.biopha.2026.119098_bib54","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/cancers13081833","article-title":"The microrna-210-stathmin1 axis decreases cell stiffness to facilitate the invasiveness of colorectal cancer stem cells","volume":"13","author":"Liao","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.biopha.2026.119098_bib55","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3390\/jcm8122115","article-title":"Molecular insights into mirna-driven resistance to 5-fluorouracil and oxaliplatin chemotherapy: mir-23b modulates the epithelial\u2013mesenchymal transition of colorectal cancer cells","volume":"8","author":"Gasiul\u0117","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13287-018-0813-5","article-title":"Gas5 is an essential lncrna regulator for self-renewal and pluripotency of mouse embryonic stem cells and induced pluripotent stem cells","volume":"9","author":"Tu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2026.119098_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2016.03.026","article-title":"Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy","volume":"92","author":"Ren","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119098_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113865","article-title":"Vps9d1-as1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer","volume":"384","author":"Yang","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2026.119098_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.969855","article-title":"Consensus molecular subtype 4 (cms4)-targeted therapy in primary colon cancer: a proof-of-concept study","volume":"12","author":"Peters","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib60","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jcp.30566","article-title":"Engineered exosomes for co-delivery of pgm5-as1 and oxaliplatin to reverse drug resistance in colon cancer","volume":"237","author":"Hui","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12951-021-01088-9","article-title":"Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by oscc","volume":"19","author":"Chen","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119098_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111678","article-title":"Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer","volume":"120","author":"Oliveira","year":"2021","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"PtA","key":"10.1016\/j.biopha.2026.119098_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2015.10.044","article-title":"Targeting cd44 expressing cancer cells with anti-cd44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin","volume":"220","author":"Arabi","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"6","key":"10.1016\/j.biopha.2026.119098_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1208\/s12249-024-02858-y","article-title":"Development, optimization, and in vitro evaluation of silybin-loaded plga nanoparticles and decoration with 5tr1 aptamer for targeted delivery to colorectal cancer cells","volume":"25","author":"Rahimnia","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2026.119098_bib65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2024.02.025","article-title":"Lipid core-shell nanoparticles co-deliver folfox regimen and sipd-l1 for synergistic targeted cancer treatment","volume":"368","author":"Cao","year":"2024","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"9","key":"10.1016\/j.biopha.2026.119098_bib66","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s11427-023-2514-y","article-title":"Circzfr promotes colorectal cancer progression via stabilizing bclaf1 and regulating the mir-3127-5p\/rtkn2 axis","volume":"67","author":"Chen","year":"2024","journal-title":"Sci. China Life Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119098_bib67","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1021\/acsptsci.4c00462","article-title":"Colon-targeted sustained-release combinatorial 5-fluorouracil and quercetin poly(lactic-co-glycolic) acid (plga) nanoparticles show enhanced apoptosis and minimal tumor drug resistance for their potential use in colon cancer, A","volume":"7","author":"Abosalha","year":"2024","journal-title":"CS Pharmacol. Transl. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7150\/ntno.25565","article-title":"Multifunctional magnetic mesoporous silica nanoagents for in vivo enzyme-responsive drug delivery and mr imaging","volume":"2","author":"Li","year":"2018","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.biopha.2026.119098_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110964","article-title":"Rbc membrane camouflaged boron nitride nanospheres for enhanced biocompatible performance","volume":"190","author":"Feng","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129841","article-title":"Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as cd44 targeted anti-cancer therapy for triple negative breast cancer","volume":"1865","author":"Basu","year":"2021","journal-title":"Biochim. Et. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.biopha.2026.119098_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.colsurfb.2014.01.017","article-title":"Hyaluronated nanoparticles with ph- and enzyme-responsive drug release properties","volume":"116","author":"Kim","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2026.119098_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156304","article-title":"Targeting samd1 enhances the effect of anti-pd-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response","volume":"170","author":"Pan","year":"2025","journal-title":"Metab. Clin. Exp."},{"issue":"26","key":"10.1016\/j.biopha.2026.119098_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500446","article-title":"Rbc membrane-camouflaged nanosystem-mediated synergistic drug combination for enhanced anti-tumor therapy","volume":"14","author":"Cheng","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib74","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3346\/jkms.2016.31.3.360","article-title":"Dual-blocking of pi3k and mtor improves chemotherapeutic effects on sw620 human colorectal cancer stem cells by inducing differentiation","volume":"31","author":"Kim","year":"2016","journal-title":"J. Korean Med. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119098_bib75","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317715155","article-title":"Upregulation of mir-199a\/b contributes to cisplatin resistance via wnt\/\u03b2-catenin-abcg2 signaling pathway in aldha1(+) colorectal cancer stem cells","volume":"39","author":"Chen","year":"2017","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119098_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3241","article-title":"Long noncoding rna arsr is associated with a poor prognosis in patients with colorectal cancer","volume":"22","author":"Li","year":"2020","journal-title":"J. gene Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/pharmaceutics16020278","article-title":"Oxaliplatin(iv) prodrugs functionalized with gemcitabine and capecitabine induce blockage of colorectal cancer cell growth-an investigation of the activation mechanism and their nanoformulation","volume":"16","author":"Marotta","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119098_bib78","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.2147\/IJN.S480168","article-title":"Hybrid biosilica nanoparticles for in-vivo targeted inhibition of colorectal cancer growth and label-free imaging","volume":"19","author":"Delle Cave","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119098_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119301","article-title":"Rbc membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo\/photothermal therapy of breast cancer","volume":"217","author":"Liu","year":"2019","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114866","article-title":"Tumor cell exosome circ-0023919 promotes emt through the mir-197-5p\/icam5 axis and enhances the drug resistance of colorectal cancer to 5-fu","volume":"455","author":"Zhang","year":"2026","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119098_bib81","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1007\/s11033-021-06680-8","article-title":"Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding rnas","volume":"48","author":"Abd-Rabou","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib82","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12951-023-02157-x","article-title":"A carrier-free supramolecular nano-twin-drug for overcoming irinotecan-resistance and enhancing efficacy against colorectal cancer","volume":"21","author":"Yuan","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119098_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213279","article-title":"Therapeutic role of biogenic silver and gold nanoparticles against a dmh-induced colon cancer model","volume":"146","author":"Mata","year":"2023","journal-title":"Biomater. Adv."},{"issue":"45","key":"10.1016\/j.biopha.2026.119098_bib84","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1039\/D2TB01518H","article-title":"Oral fullerene tablets for colorectal cancer therapy based on modulation of tumor inflammatory microenvironments","volume":"10","author":"Cao","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2026.119098_bib85","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jconrel.2020.09.034","article-title":"Manipulating immune system using nanoparticles for an effective cancer treatment: combination of targeted therapy and checkpoint blockage mirna","volume":"329","author":"Nguyen","year":"2021","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"15","key":"10.1016\/j.biopha.2026.119098_bib86","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1039\/D4RA08547G","article-title":"Manganese-based nanoparticles plus gambogic acid targeted hypoxic tumor microenvironment by enhancing ros generation and provided antitumor treatment and improved immunotherapy","volume":"15","author":"Liang","year":"2025","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib87","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1038\/s41467-023-39640-w","article-title":"Mutant apc reshapes wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic \u03b2-catenin","volume":"14","author":"Erazo-Oliveras","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12951-021-00981-7","article-title":"Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncrna ccat1 silencing and curcumin delivery for synchronous colorectal cancer theranostics","volume":"19","author":"Jia","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119098_bib89","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2147\/IJN.S189923","article-title":"Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer","volume":"14","author":"Zhao","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119098_bib90","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2020.01.040","article-title":"Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity","volume":"320","author":"Jin","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2026.119098_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124007","article-title":"Red blood cell membrane-camouflaged gold-core silica shell nanorods for cancer drug delivery and photothermal therapy","volume":"655","author":"Rodrigues","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"19","key":"10.1016\/j.biopha.2026.119098_bib92","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1021\/acs.analchem.2c00477","article-title":"Upconversion nanoparticle@au core-satellite assemblies for in situ amplified imaging of microrna in living cells and combined cancer phototherapy","volume":"94","author":"Yang","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biopha.2026.119098_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122850","article-title":"Sequential-delivery nanocomplex for combined anti-angiogenesis and gene therapy against colorectal cancer","volume":"637","author":"Jia","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib94","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41467-022-29309-1","article-title":"Pumilio proteins promote colorectal cancer growth via suppressing p21","volume":"13","author":"Gong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119098_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121485","article-title":"Lncrna-targeting bio-scaffold mediates triple immune effects for postoperative colorectal cancer immunotherapy","volume":"284","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119098_bib96","article-title":"Exosome-derived circ_0094343 promotes chemosensitivity of colorectal cancer cells by regulating glycolysis via the mir-766-5p\/trim67 axis","volume":"2022","author":"Li","year":"2022","journal-title":"Contrast Media Mol. Imaging"},{"issue":"7","key":"10.1016\/j.biopha.2026.119098_bib97","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s11010-020-03856-x","article-title":"Lncrna kcnq1ot1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells","volume":"476","author":"Zheng","year":"2021","journal-title":"Mol. Cell. Biochem"},{"issue":"5","key":"10.1016\/j.biopha.2026.119098_bib98","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.molpharmaceut.2c00876","article-title":"Combining \u03b2-carotene with 5-fu via polymeric nanoparticles as a novel therapeutic strategy to overcome ul3-mediated chemoresistance in p53-deleted colorectal cancer cells","volume":"20","author":"Carotenuto","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2026.119098_bib99","first-page":"126","article-title":"Crcs-cafs crosstalk-targeted nano-delivery system reprograms tumor microenvironment for oxaliplatin resistance reversing and liver metastasis inhibition in colorectal cancer","volume":"54","author":"Liu","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2026.119098_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120888","article-title":"A folate-targeted pegylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and sirna for colorectal cancer","volume":"606","author":"Zou","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119098_bib101","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10517-024-06026-x","article-title":"A validation study of cd133 as a reliable marker for identification of colorectal cancer stem-like cells","volume":"176","author":"You","year":"2024","journal-title":"Bull. Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119098_bib102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/pharmaceutics17040469","article-title":"Targeted delivery of chlorin-e6-loaded carbon nanotube-based nanobiocomposite to cancer stem cells for enhanced photodynamic therapy","volume":"17","author":"Sundaram","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib103","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3892\/mmr.2013.1760","article-title":"Pien tze huang suppresses the stem-like side population in colorectal cancer cells","volume":"9","author":"Wei","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119098_bib104","first-page":"635","article-title":"Quercetin induces cell cycle arrest and apoptosis in cd133(+) cancer stem cells of human colorectal ht29 cancer cell line and enhances anticancer effects of doxorubicin, Iran","volume":"18","author":"Atashpour","year":"2015","journal-title":"J. Basic Med. Sci."},{"key":"10.1016\/j.biopha.2026.119098_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121856","article-title":"Activating cgas-sting pathway with ros-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy","volume":"290","author":"Cao","year":"2022","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biopha.2026.119098_bib106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3892\/or.2023.8566","article-title":"Knockdown of hnrnpab reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells","volume":"49","author":"Zhou","year":"2023","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119098_bib107","article-title":"Lipid nanoparticle-mediated sirna transfer against pctaire1\/pctk1\/cdk16 inhibits in vivo cancer growth","volume":"5","author":"Yanagi","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib108","first-page":"232","article-title":"Tm4sf1 promotes emt and cancer stemness via the wnt\/\u03b2-catenin\/sox2 pathway in colorectal cancer","volume":"39","author":"Tang","year":"2020","journal-title":"Journal Experimental Clinical Cancer Research CR"},{"key":"10.1016\/j.biopha.2026.119098_bib109","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2023.12.018","article-title":"Rna-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer","volume":"366","author":"Zhou","year":"2024","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"5","key":"10.1016\/j.biopha.2026.119098_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201889","article-title":"Liquid core nanoparticle with high deformability enables efficient penetration across biological barriers","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"33","key":"10.1016\/j.biopha.2026.119098_bib111","doi-asserted-by":"crossref","first-page":"38172","DOI":"10.1021\/acsami.2c09404","article-title":"Pt\/dox nanomotors enhance penetration in the deep tumor by positive chemotaxis","volume":"14","author":"Zhong","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib112","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41392-024-01983-1","article-title":"Sequential responsive nano-protacs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119098_bib113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2016.11.013","article-title":"Chitosan nanoparticles as a dual drug\/sirna delivery system for treatment of colorectal cancer","volume":"181","author":"Sadreddini","year":"2017","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib114","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2021.06.005","article-title":"A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside rg3 and quercetin for chemo-immunotherapy in colorectal cancer","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12951-024-02416-5","article-title":"Drug repurposing-based nanoplatform via modulating autophagy to enhance chemo-phototherapy against colorectal cancer","volume":"22","author":"Ding","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119098_bib116","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3389\/fgene.2019.01096","article-title":"Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer","volume":"10","author":"Pan","year":"2019","journal-title":"Front. Genet"},{"issue":"8","key":"10.1016\/j.biopha.2026.119098_bib117","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1021\/acs.analchem.3c05064","article-title":"Engineering logic dna nanoprobes on live cell membranes for simultaneously monitoring extracellular ph and precise drug delivery","volume":"96","author":"Chen","year":"2024","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119098_bib118","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1021\/ja510479v","article-title":"Magnetic resonance imaging of tumor with a self-traceable phosphorylcholine polymer","volume":"137","author":"Yamada","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119098_bib119","doi-asserted-by":"crossref","first-page":"31239","DOI":"10.34172\/bi.31239","article-title":"Role of non-coding rna through nanomedicine: the novel therapeutic and diagnostic approaches","volume":"15","author":"Khoshnevisan","year":"2025","journal-title":"BioImpacts BI"},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib120","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1038\/s41467-022-32198-z","article-title":"Molecular characterization of colorectal cancer related peritoneal metastatic disease","volume":"13","author":"Lenos","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119098_bib121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-019-1122-z","article-title":"Hypoxia induced lucat1\/ptbp1 axis modulates cancer cell viability and chemotherapy response","volume":"19","author":"Huan","year":"2020","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.biopha.2026.119098_bib122","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.3390\/cancers14215175","article-title":"Molecular classification of colorectal cancer by microrna profiling: correlation with the consensus molecular subtypes (cms) and validation of mir-30b targets","volume":"14","author":"Paz-Cabezas","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.biopha.2026.119098_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70171","article-title":"Mesenchymal colorectal cancers secrete vesicles with unique cargo that can be used for liquid biopsy based diagnostics","volume":"14","author":"Asif","year":"2025","journal-title":"J. Extracell. Vesicles"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:43:37Z","timestamp":1781880217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":123,"alternative-id":["S0753332226001307"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119098","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNA Trojan nanocarriers in CRC: Mechanistic crossroads and therapeutic challenges","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119098"}}